Kensuke Nomura

444 total citations
11 papers, 300 citations indexed

About

Kensuke Nomura is a scholar working on Psychiatry and Mental health, Clinical Psychology and Philosophy. According to data from OpenAlex, Kensuke Nomura has authored 11 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 4 papers in Clinical Psychology and 3 papers in Philosophy. Recurrent topics in Kensuke Nomura's work include Schizophrenia research and treatment (10 papers), Obsessive-Compulsive Spectrum Disorders (4 papers) and Mental Health and Psychiatry (3 papers). Kensuke Nomura is often cited by papers focused on Schizophrenia research and treatment (10 papers), Obsessive-Compulsive Spectrum Disorders (4 papers) and Mental Health and Psychiatry (3 papers). Kensuke Nomura collaborates with scholars based in Japan, Canada and United States. Kensuke Nomura's co-authors include Takefumi Suzuki, Haruo Kashima, Koichiro Watanabe, Hiroyuki Uchida, Gohei Yagi, Akira Tanabe, Hiroyoshi Takeuchi, Shinichiro Nakajima, Issei Takeuchi and Kimiko Makino and has published in prestigious journals such as Psychopharmacology, Colloids and Surfaces B Biointerfaces and The International Journal of Neuropsychopharmacology.

In The Last Decade

Kensuke Nomura

11 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kensuke Nomura Japan 9 236 59 58 52 34 11 300
Mark D. Watanabe United States 7 252 1.1× 66 1.1× 84 1.4× 60 1.2× 4 0.1× 11 414
Michelle C. Sullivan United States 6 281 1.2× 31 0.5× 65 1.1× 33 0.6× 18 0.5× 6 444
T Schut Netherlands 9 137 0.6× 22 0.4× 47 0.8× 107 2.1× 13 0.4× 21 447
Valerie Powell Canada 10 217 0.9× 18 0.3× 24 0.4× 41 0.8× 10 0.3× 18 321
Boris Zoubok United States 4 329 1.4× 53 0.9× 56 1.0× 21 0.4× 16 0.5× 8 429
Olubanke Olofinjana United Kingdom 7 195 0.8× 41 0.7× 47 0.8× 79 1.5× 3 0.1× 8 322
Lara McCartney Australia 5 402 1.7× 102 1.7× 76 1.3× 48 0.9× 7 0.2× 5 495
S. Heylen Belgium 7 452 1.9× 96 1.6× 94 1.6× 97 1.9× 9 0.3× 11 560
R.B. Zipursky Canada 6 198 0.8× 36 0.6× 36 0.6× 49 0.9× 8 0.2× 10 266
Ilona Mirecki Israel 9 260 1.1× 41 0.7× 64 1.1× 64 1.2× 6 0.2× 12 392

Countries citing papers authored by Kensuke Nomura

Since Specialization
Citations

This map shows the geographic impact of Kensuke Nomura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kensuke Nomura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kensuke Nomura more than expected).

Fields of papers citing papers by Kensuke Nomura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kensuke Nomura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kensuke Nomura. The network helps show where Kensuke Nomura may publish in the future.

Co-authorship network of co-authors of Kensuke Nomura

This figure shows the co-authorship network connecting the top 25 collaborators of Kensuke Nomura. A scholar is included among the top collaborators of Kensuke Nomura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kensuke Nomura. Kensuke Nomura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Takeuchi, Issei, Kensuke Nomura, & Kimiko Makino. (2017). Hydrophobic boron compound-loaded poly(l-lactide-co-glycolide) nanoparticles for boron neutron capture therapy. Colloids and Surfaces B Biointerfaces. 159. 360–365. 35 indexed citations
2.
Suzuki, Takefumi, Hiroyoshi Takeuchi, Shinichiro Nakajima, et al.. (2010). Magnitude of Rater Differences in Assessment Scales for Schizophrenia. Journal of Clinical Psychopharmacology. 30(5). 607–611. 6 indexed citations
3.
Uchida, Hiroyuki, Takefumi Suzuki, David C. Mamo, et al.. (2009). Survey of benzodiazepine and antidepressant use in outpatients with mood disorders in Japan. Psychiatry and Clinical Neurosciences. 63(2). 244–246. 15 indexed citations
4.
Suzuki, Takefumi, Hiroyuki Uchida, Hiroyoshi Takeuchi, et al.. (2009). Augmentation of atypical antipsychotics with valproic acid. An open‐label study for most difficult patients with schizophrenia. Human Psychopharmacology Clinical and Experimental. 24(8). 628–638. 36 indexed citations
5.
6.
Takeuchi, Hiroyoshi, Takefumi Suzuki, Hiroyuki Uchida, et al.. (2008). A Randomized, Open-Label Comparison of 2 Switching Strategies to Aripiprazole Treatment in Patients With Schizophrenia. Journal of Clinical Psychopharmacology. 28(5). 540–543. 29 indexed citations
7.
8.
Suzuki, Takefumi, Hiroyuki Uchida, Hiroyoshi Takeuchi, et al.. (2005). Simplifying psychotropic medication regimen into a single night dosage and reducing the dose for patients with chronic schizophrenia. Psychopharmacology. 181(3). 566–575. 17 indexed citations
9.
Suzuki, Takefumi, Hiroyuki Uchida, Kenji F. Tanaka, et al.. (2004). Revising polypharmacy to a single antipsychotic regimen for patients with chronic schizophrenia. The International Journal of Neuropsychopharmacology. 7(2). 133–142. 56 indexed citations
10.
Suzuki, Takefumi, Hiroyuki Uchida, Kenji F. Tanaka, et al.. (2003). Reducing the dose of antipsychotic medications for those who had been treated with high-dose antipsychotic polypharmacy: an open study of dose reduction for chronic schizophrenia. International Clinical Psychopharmacology. 18(6). 323–329. 31 indexed citations
11.
Suzuki, Takefumi, Hiroyuki Uchida, Kenji F. Tanaka, et al.. (2003). Reducing the dose of antipsychotic medications for those who had been treated with high-dose antipsychotic polypharmacy: an open study of dose reduction for chronic schizophrenia. International Clinical Psychopharmacology. 18(6). 323–329. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark D. Watanabe Breakdown of academic impact, for papers by Michelle C. Sullivan Breakdown of academic impact, for papers by T Schut Breakdown of academic impact, for papers by Valerie Powell Breakdown of academic impact, for papers by Boris Zoubok Breakdown of academic impact, for papers by Olubanke Olofinjana Breakdown of academic impact, for papers by Lara McCartney Breakdown of academic impact, for papers by S. Heylen Breakdown of academic impact, for papers by R.B. Zipursky Breakdown of academic impact, for papers by Ilona Mirecki
Rankless by CCL
2026